• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于疫苗不良事件报告系统数据的不良效应时间变化的信号检测方法。

A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data.

机构信息

Pieces Technology, 8435 N Stemmons Fwy #1150, Dallas, TX, USA.

School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, USA.

出版信息

BMC Med Inform Decis Mak. 2017 Jul 5;17(Suppl 2):76. doi: 10.1186/s12911-017-0472-y.

DOI:10.1186/s12911-017-0472-y
PMID:28699543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5506615/
Abstract

BACKGROUND

To identify safety signals by manual review of individual report in large surveillance databases is time consuming; such an approach is very unlikely to reveal complex relationships between medications and adverse events. Since the late 1990s, efforts have been made to develop data mining tools to systematically and automatically search for safety signals in surveillance databases. Influenza vaccines present special challenges to safety surveillance because the vaccine changes every year in response to the influenza strains predicted to be prevalent that year. Therefore, it may be expected that reporting rates of adverse events following flu vaccines (number of reports for a specific vaccine-event combination/number of reports for all vaccine-event combinations) may vary substantially across reporting years. Current surveillance methods seldom consider these variations in signal detection, and reports from different years are typically collapsed together to conduct safety analyses. However, merging reports from different years ignores the potential heterogeneity of reporting rates across years and may miss important safety signals.

METHOD

Reports of adverse events between years 1990 to 2013 were extracted from the Vaccine Adverse Event Reporting System (VAERS) database and formatted into a three-dimensional data array with types of vaccine, groups of adverse events and reporting time as the three dimensions. We propose a random effects model to test the heterogeneity of reporting rates for a given vaccine-event combination across reporting years. The proposed method provides a rigorous statistical procedure to detect differences of reporting rates among years. We also introduce a new visualization tool to summarize the result of the proposed method when applied to multiple vaccine-adverse event combinations.

RESULT

We applied the proposed method to detect safety signals of FLU3, an influenza vaccine containing three flu strains, in the VAERS database. We showed that it had high statistical power to detect the variation in reporting rates across years. The identified vaccine-event combinations with significant different reporting rates over years suggested potential safety issues due to changes in vaccines which require further investigation.

CONCLUSION

We developed a statistical model to detect safety signals arising from heterogeneity of reporting rates of a given vaccine-event combinations across reporting years. This method detects variation in reporting rates over years with high power. The temporal trend of reporting rate across years may reveal the impact of vaccine update on occurrence of adverse events and provide evidence for further investigations.

摘要

背景

通过手动审查大型监测数据库中的个体报告来识别安全信号非常耗时;这种方法不太可能揭示药物与不良事件之间的复杂关系。自 20 世纪 90 年代末以来,人们一直在努力开发数据挖掘工具,以便在监测数据库中系统地自动搜索安全信号。流感疫苗对安全性监测提出了特殊挑战,因为疫苗每年都会根据当年预测流行的流感菌株进行更新。因此,可以预期流感疫苗接种后不良事件(特定疫苗-事件组合的报告数/所有疫苗-事件组合的报告数)的报告率在报告年度之间会有很大差异。当前的监测方法很少考虑到信号检测中的这些变化,不同年份的报告通常合并在一起进行安全性分析。然而,合并来自不同年份的报告忽略了报告率在各年之间的潜在异质性,并且可能会错过重要的安全信号。

方法

从疫苗不良事件报告系统(VAERS)数据库中提取了 1990 年至 2013 年期间的不良事件报告,并将其格式化为具有疫苗类型、不良事件组和报告时间作为三个维度的三维数据数组。我们提出了一个随机效应模型来测试给定疫苗-事件组合在报告年度之间的报告率的异质性。该方法提供了一种严格的统计程序,用于检测各年报告率之间的差异。我们还引入了一种新的可视化工具,用于总结应用于多个疫苗-不良事件组合时该方法的结果。

结果

我们将提出的方法应用于 VAERS 数据库中含三种流感株的流感疫苗 FLU3 的安全性信号检测。结果表明,该方法具有很高的统计功效,可以检测各年报告率之间的变化。确定的在各年报告率存在显著差异的疫苗-事件组合提示由于疫苗变化而可能存在安全问题,需要进一步调查。

结论

我们开发了一种统计模型,用于检测给定疫苗-事件组合在报告年度之间报告率的异质性引起的安全信号。该方法具有较高的功效,可以检测各年报告率的变化。各年报告率的时间趋势可以揭示疫苗更新对不良事件发生的影响,并为进一步调查提供证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/2f37717fd618/12911_2017_472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/28bd0bf60e57/12911_2017_472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/811df7b5c42d/12911_2017_472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/2f37717fd618/12911_2017_472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/28bd0bf60e57/12911_2017_472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/811df7b5c42d/12911_2017_472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ba/5506615/2f37717fd618/12911_2017_472_Fig3_HTML.jpg

相似文献

1
A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data.一种基于疫苗不良事件报告系统数据的不良效应时间变化的信号检测方法。
BMC Med Inform Decis Mak. 2017 Jul 5;17(Suppl 2):76. doi: 10.1186/s12911-017-0472-y.
2
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
3
Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.利用数据挖掘技术对疫苗不良事件报告系统(VAERS)中的安全信号进行前瞻性早期检测:2010-2011 年季节性流感病毒疫苗接种后发热性惊厥的病例研究。
Drug Saf. 2013 Jul;36(7):547-56. doi: 10.1007/s40264-013-0051-9.
4
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.从疫苗不良事件报告系统中了解疫苗安全信息。
Pediatr Infect Dis J. 2004 Apr;23(4):287-94. doi: 10.1097/00006454-200404000-00002.
5
Comparing data mining methods on the VAERS database.在疫苗不良事件报告系统(VAERS)数据库上比较数据挖掘方法。
Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):601-9. doi: 10.1002/pds.1107.
6
Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS).美国疫苗不良事件报告系统(VAERS)中的关联规则挖掘。
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):922-33. doi: 10.1002/pds.3797. Epub 2015 Jun 4.
7
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.美国2005年7月至2013年6月,成人三价减毒活流感疫苗上市后监测,疫苗不良事件报告系统(VAERS)
Vaccine. 2014 Nov 12;32(48):6499-504. doi: 10.1016/j.vaccine.2014.09.018. Epub 2014 Sep 22.
8
Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.为全球引入灭活脊髓灰质炎病毒疫苗做准备:来自美国疫苗不良事件报告系统的安全性证据,2000-2012 年。
Lancet Infect Dis. 2015 Oct;15(10):1175-1182. doi: 10.1016/S1473-3099(15)00059-6. Epub 2015 Aug 16.
9
Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.美国疫苗不良事件报告系统(VAERS)中的数据挖掘:轮状病毒疫苗接种后肠套叠及其他事件的早期检测
Vaccine. 2001 Sep 14;19(32):4627-34. doi: 10.1016/s0264-410x(01)00237-7.
10
Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.1990 年至 2014 年向疫苗不良事件报告系统(VAERS)报告的主要出生缺陷。
Birth Defects Res. 2017 Jul 17;109(13):1057-1062. doi: 10.1002/bdr2.23622.

引用本文的文献

1
Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis.美国 COVID-19 疫苗的不良事件:时空分析。
JMIR Public Health Surveill. 2024 Jul 15;10:e51007. doi: 10.2196/51007.
2
Lessons learned from annotation of VAERS reports on adverse events following influenza vaccination and related to Guillain-Barré syndrome.从 VAERS 报告中关于流感疫苗接种后不良事件的注释以及与吉兰-巴雷综合征相关的注释中吸取的教训。
BMC Med Inform Decis Mak. 2024 Jan 5;23(Suppl 4):298. doi: 10.1186/s12911-023-02374-2.
3
Association of Cardiovascular Events with COVID-19 Vaccines Using Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study.

本文引用的文献

1
Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience.麻疹、腮腺炎和风疹病毒疫苗(M-M-R™II):32 年临床和上市后经验回顾。
Vaccine. 2012 Nov 6;30(48):6918-26. doi: 10.1016/j.vaccine.2012.08.057. Epub 2012 Sep 7.
2
On the asymptotic behaviour of the pseudolikelihood ratio test statistic with boundary problems.关于具有边界问题的伪似然比检验统计量的渐近行为
Biometrika. 2010 Sep;97(3):603-620. doi: 10.1093/biomet/asq031. Epub 2010 Jun 11.
3
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.
使用疫苗不良事件报告系统 (VAERS) 评估心血管事件与 COVID-19 疫苗的相关性:一项回顾性研究。
Curr Drug Saf. 2024;19(3):402-406. doi: 10.2174/0115748863276904231108095255.
4
Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.利用本体挖掘大型频率表中的不良事件,在疫苗不良事件报告系统中的应用。
Stat Med. 2023 May 10;42(10):1512-1524. doi: 10.1002/sim.9684. Epub 2023 Feb 15.
5
Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system.基于被动监测系统数据预测疫苗接种后吉兰-巴雷综合征。
Pharmacoepidemiol Drug Saf. 2021 May;30(5):602-609. doi: 10.1002/pds.5196. Epub 2021 Feb 23.
6
Identification of Rare Adverse Events with Year-varying Reporting Rates for FLU4 Vaccine in VAERS.通过疫苗不良事件报告系统(VAERS)中流感疫苗4(FLU4)逐年变化的报告率识别罕见不良事件。
AMIA Annu Symp Proc. 2018 Dec 5;2018:1544-1551. eCollection 2018.
7
Introduction: the International Conference on Intelligent Biology and Medicine (ICIBM) 2016: special focus on medical informatics and big data.介绍:2016 年国际智能生物学与医学会议(ICIBM):特别关注医学信息学和大数据。
BMC Med Inform Decis Mak. 2017 Jul 5;17(Suppl 2):77. doi: 10.1186/s12911-017-0462-0.
流感疫苗株的选择及近期关于季节性流感病毒全球传播的研究。
Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. doi: 10.1016/j.vaccine.2008.07.078.
4
The reporting odds ratio and its advantages over the proportional reporting ratio.报告比值比及其相对于比例报告比值比的优势。
Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23. doi: 10.1002/pds.1001.
5
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.使用比例报告比(PRR)从自发药物不良反应报告中生成信号。
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6. doi: 10.1002/pds.677.
6
A Bayesian neural network method for adverse drug reaction signal generation.一种用于药物不良反应信号生成的贝叶斯神经网络方法。
Eur J Clin Pharmacol. 1998 Jun;54(4):315-21. doi: 10.1007/s002280050466.
7
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH).人用药品注册技术要求国际协调会议(ICH)
Br J Clin Pharmacol. 1994 May;37(5):401-4. doi: 10.1111/j.1365-2125.1994.tb05705.x.